12 results for author:"Cohn J.S." in Literature citations
Results Customize
| Complexities of plasma apolipoprotein C-III metabolism. Sacks F.M., Zheng C., Cohn J.S. J. Lipid Res. 52:1067-1070(2011) · Mapped (3) |
| Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I. Reimers G.J., Jackson C.L., Rickards J., Chan P.Y., Cohn J.S., Rye K.A., Barter P.J., Rodgers K.J. Cardiovasc. Res. 91:37-44(2011) · Mapped (4) |
| High expression of apolipoprotein E impairs lipid storage and promotes cell proliferation in human adipocytes. Carmel J.F., Tarnus E., Cohn J.S., Bourdon E., Davignon J., Bernier L. J. Cell. Biochem. 106:608-617(2009) · Mapped (16) |
| Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism. Millar J.S., Brousseau M.E., Diffenderfer M.R., Barrett P.H., Welty F.K., Cohn J.S., Wilson A., Wolfe M.L., Nartsupha C., Schaefer P.M. et al. J. Lipid Res. 49:543-549(2008) · Mapped (11) |
| Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Duez H., Lamarche B., Uffelman K.D., Valero R., Cohn J.S., Lewis G.F. Arterioscler. Thromb. Vasc. Biol. 26:1357-1363(2006) · Mapped (12) |
| Apolipoproteins C-II and C-III inhibit selective uptake of low- and high-density lipoprotein cholesteryl esters in HepG2 cells. Huard K., Bourgeois P., Rhainds D., Falstrault L., Cohn J.S., Brissette L. Int. J. Biochem. Cell Biol. 37:1308-1318(2005) · Mapped (5) |
| The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children. Shachter N.S., Rabinowitz D., Stohl S., Conde-Knape K., Cohn J.S., Deckelbaum R.J., Berglund L., Shea S. Atherosclerosis 179:387-393(2005) · Mapped (2) |
| Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies. Qiu W., Avramoglu R.K., Dube N., Chong T.M., Naples M., Au C., Sidiropoulos K.G., Lewis G.F., Cohn J.S., Tremblay M.L. et al. Diabetes 53:3057-3066(2004) · Mapped (17) |
| Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. Hirsch-Reinshagen V., Zhou S., Burgess B.L., Bernier L., McIsaac S.A., Chan J.Y., Tansley G.H., Cohn J.S., Hayden M.R., Wellington C.L. J. Biol. Chem. 279:41197-41207(2004) · Mapped (18) |
| Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism. Cohn J.S., Tremblay M., Boulet L., Jacques H., Davignon J., Roy M., Bernier L. Atherosclerosis 169:63-70(2003) · Mapped (2) |
| Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase. Conde-Knape K., Bensadoun A., Sobel J.H., Cohn J.S., Shachter N.S. J. Lipid Res. 43:2136-2145(2002) · Mapped (13) |
| Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Ramassamy C., Averill D., Beffert U., Theroux L., Lussier-Cacan S., Cohn J.S., Christen Y., Schoofs A., Davignon J., Poirier J. Neurobiol. Dis. 7:23-37(2000) · Mapped (18) |